Flora Double Ginger Herbal Tea Blend, 16/1.24 oz (35.2g) tea bags per package.
Recalling firm: Flora Inc
Flora Double Ginger Herbal Tea Blend 1.24 oz was recalled due to contamination with Salmonella.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Apr 9, 2014.
Check your package
Compare the exact product and package details with the label you have.
061998637579FDA code information
BB/MA: 2019-09, LOT: 13268 10314 19R8F 268:17:49 Give a breakdown of the code: BB/MA = Best before date 2016-09; LOT 1326810314; 19RF = Organic number 268:17:49 = Manufacturing date and time
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Flora Double Ginger Herbal Tea Blend, 16/1.24 oz (35.2g) tea bags per package. UPC 0 61998 63757 9 The product is labeled in parts: "***DOUBLE GINGER HERBAL TEA BLEND***FLORA***CERTIFIED ORGANIC***FRESH-SEALED TEA BAGS***16***NET WT 1.24 oz***(35.2 g)***INGREDIENTS: GINGER ROOT, LEMONGRASS HERB, PEPPERMINT LEAVES, LICORICE ROOT, BLACK PEPPER SEEDS, *ORGANIC***IMPORTED BY: FLORA INC., 805 E. BADGER RD. LYNDEN, WA***".
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 061998637579 | a Double Ginger Herbal Tea Blend, 16/1.24 oz (35.2g) tea bags per package. UPC 0 61998 63757 9 The product is labeled in parts: "***DOUBLE GINGER HERBAL TEA BLEND***FLORA***CERTIFIED ORGANIC***FRESH-SEALED TEA B |
Original FDA recall reason
Flora Double Ginger Herbal Tea Blend 1.24 oz was recalled due to contamination with Salmonella.
Recall details
- Recall number
- F-1110-2014
- Event ID
- 66959
- FDA status
- Terminated
- Initiated
- Nov 18, 2013
- Reported
- Dec 25, 2013
- Classified
- Dec 18, 2013
- Terminated
- Apr 9, 2014
- Quantity
- 6024 boxes (16 tea bags per box)
- Location
- Lynden, WA, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
Distributed in the following states: FL, GA, IL, IN, KY, MD, MI, NC, NJ, NV, NY, OH, PA, and SC.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.